Remifentanil-Induced Secondary Hyperalgesia Is Not Prevented By Preoperative Acetazolamide Administration In Patients Undergoing Total Thyroidectomy: A Randomized Controlled Trial.
Rodrigo GutiérrezFelipe ContrerasAlonso BlanchDaniela BravoJosé I EgañaDaniel RappoportPatricio CabanéFrancisco RodríguezAntonello PennaPublished in: Journal of pain research (2019)
Both groups developed remifentanil-mediated OIH at 12-18 h after surgery. However, ACTZ did not prevent the MPT reduction in patients undergoing total thyroidectomy.